{"id":"W2603924317","doi":"10.1111/bjh.14569","title":"A phase 1 trial of temsirolimus and intensive re-induction chemotherapy for 2nd or greater relapse of acute lymphoblastic leukaemia: a Children's Oncology Group study (ADVL1114)","year":2017,"lang":"en","type":"article","venue":"British Journal of Haematology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"National Institutes of Health; Leukemia and Lymphoma Society; National Cancer Institute; Rally Foundation","keywords":"Temsirolimus; Medicine; Mucositis; Internal medicine; Toxicity; Regimen; Induction chemotherapy; Sirolimus; Clinical endpoint; Chemotherapy; Gastroenterology; Oncology; Clinical trial; PI3K/AKT/mTOR pathway; Discovery and development of mTOR inhibitors; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001136424,0.001169336,0.001706348,0.0003619148,0.0002052892,0.0005371338,0.0007413557,0.0009030118,0.00292612],"category_scores_gemma":[0.0005910238,0.0004962691,0.0007331291,0.000339421,0.0007808811,0.0003914495,0.0003402228,0.002701812,0.0005748659],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007785585,"about_ca_system_score_gemma":0.00109069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000764551,"about_ca_topic_score_gemma":0.0020451,"domain_scores_codex":[0.9996994,0.0001662214,0.00001146256,0.00004849555,0.00002492115,0.00004959547],"domain_scores_gemma":[0.9994898,0.00009574086,0.0001165056,0.0000558313,0.00001437629,0.0002277314],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7386949,0.06469446,0.009798363,0.0009911547,0.001286632,0.000483335,0.0004273499,0.003673384,0.05275051,0.0005995134,0.004935225,0.1216652],"study_design_scores_gemma":[0.5731153,0.401119,0.01545615,0.00003395893,0.0003328755,0.0006007966,0.00004549128,0.0008725917,0.004276415,0.0002021552,0.00391751,0.00002789562],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9963675,0.000934621,0.0001815254,0.0002039393,0.00004746098,0.0009110362,0.000401564,0.00005011224,0.0009021788],"genre_scores_gemma":[0.9884671,0.001694265,0.001599804,0.000590258,0.0001215189,0.00205887,0.002362757,0.00002705056,0.003078393],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00292612,"threshold_uncertainty_score":0.009788811,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02386398180393254,"score_gpt":0.336079125056828,"score_spread":0.3122151432528955,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}